Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Anemia

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    February 2024
  1. ZHANG Y, Martin B, Spies MA, Roberts SM, et al
    Renin and renin blockade have no role in complement activity.
    Kidney Int. 2024;105:328-337.
    PubMed     Abstract available


    January 2024
  2. KAARTINEN K, Schenk P, Raisanen-Sokolowski A, Dunkel J, et al
    The Case | Refractory anemia in a patient undergoing dialysis.
    Kidney Int. 2024;105:211-212.
    PubMed    


    October 2023
  3. HUERTA A, Arjona E, Portoles J, Lopez-Sanchez P, et al
    On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome.
    Kidney Int. 2023;104:851-855.
    PubMed    


    September 2023
  4. ECKARDT KU, Kurtz A
    Secrets and myths between tubules - new insights on erythropoietin production from single cell technology.
    Kidney Int. 2023 Sep 13:S0085-2538(23)00634-8. doi: 10.1016/j.kint.2023.
    PubMed    


    August 2023
  5. LABOUX T, Maanaoui M, Allain F, Boulanger E, et al
    Hemolysis is associated with altered heparan sulfate of the endothelial glycocalyx and with local complement activation in thrombotic microangiopathies.
    Kidney Int. 2023;104:353-366.
    PubMed     Abstract available


    July 2023
  6. KOURY MJ, Haase VH
    Deregulating iron-erythropoiesis regulation: transferrin receptor 2 as potential target for treating anemia in CKD.
    Kidney Int. 2023;104:25-28.
    PubMed     Abstract available


    June 2023
  7. LOCATELLI F, Del Vecchio L
    Quality of life: a crucial aspect for the patients, a neglected goal in the treatment of anemia in patients with CKD.
    Kidney Int. 2023;103:1025-1027.
    PubMed     Abstract available


    May 2023
  8. KU E, Del Vecchio L, Eckardt KU, Haase VH, et al
    Novel Anemia Therapies in CKD: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2023 May 24:S0085-2538(23)00379-4. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available


    March 2023
  9. OLIVARI V, Di Modica SM, Lidonnici MR, Aghajan M, et al
    A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.
    Kidney Int. 2023 Mar 27:S0085-2538(23)00179-5. doi: 10.1016/j.kint.2023.
    PubMed     Abstract available


    November 2022
  10. KETTRITZ R, Duttmann W, Brand A, Luft FC, et al
    The Case | Is this hemolytic uremic syndrome?
    Kidney Int. 2022;102:1195-1196.
    PubMed    


    August 2022
  11. FUCHS MAA, Kurtz A
    The fate of erythropoietin-producing cells: another piece of the puzzle.
    Kidney Int. 2022;102:230-233.
    PubMed     Abstract available


    June 2022
  12. BATTE A, Menon S, Ssenkusu JM, Kiguli S, et al
    Neutrophil gelatinase-associated lipocalin is elevated in children with acute kidney injury and sickle cell anemia, and predicts mortality.
    Kidney Int. 2022 Jun 16. pii: S0085-2538(22)00453.
    PubMed     Abstract available


  13. VAN DEN BROEK B, van der Flier M, van de Kar NCAJ, Wetzels JFM, et al
    Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C.
    Kidney Int. 2022;101:1293-1295.
    PubMed    


  14. WAGENER FADTG, van de Kar NCAJ, van den Heuvel LP
    Protective mechanisms harnessing against injurious heme and preventing kidney damage in STEC-HUS: toward new therapies?
    Kidney Int. 2022;101:1107-1109.
    PubMed     Abstract available


  15. PIRSCHEL W, Mestekemper AN, Wissuwa B, Krieg N, et al
    Divergent roles of haptoglobin and hemopexin deficiency for disease progression of Shiga-toxin-induced hemolytic-uremic syndrome in mice.
    Kidney Int. 2022;101:1171-1185.
    PubMed     Abstract available


    May 2022
  16. KANEKO K, Sato Y, Uchino E, Toriu N, et al
    Lineage tracing analysis defines erythropoietin-producing cells as a distinct subpopulation of resident fibroblasts with unique behaviors.
    Kidney Int. 2022 May 26. pii: S0085-2538(22)00376.
    PubMed     Abstract available


  17. LABES R, Brinkmann L, Kulow VA, Roegner K, et al
    Daprodustat prevents Cyclosporine-A mediated anemia and peritubular capillary loss.
    Kidney Int. 2022 May 25. pii: S0085-2538(22)00375.
    PubMed     Abstract available


    April 2022
  18. HANUDEL MR, Czaya B, Wong S, Rappaport M, et al
    Enteral ferric citrate absorption is dependent on the iron transport protein ferroportin.
    Kidney Int. 2022;101:711-719.
    PubMed     Abstract available


  19. HAASE VH
    The ins and outs of ferric citrate.
    Kidney Int. 2022;101:668-670.
    PubMed     Abstract available


    March 2022
  20. JOLES JA
    Anemia and red blood cell deformability in proteinuric chronic kidney disease.
    Kidney Int. 2022;101:649.
    PubMed    


    December 2021
  21. DRUEKE TB, Massy ZA
    Role of proteinuria in the anemia of chronic kidney disease.
    Kidney Int. 2021;100:1160-1162.
    PubMed     Abstract available


    September 2021
  22. BISSINGER R, Nemkov T, D Alessandro A, Grau M, et al
    Proteinuric chronic kidney disease is associated with altered red blood cell lifespan, deformability and metabolism.
    Kidney Int. 2021 Sep 16. pii: S0085-2538(21)00858.
    PubMed     Abstract available


    August 2021
  23. LILL JK, Thiebes S, Pohl JM, Bottek J, et al
    Tissue-resident macrophages mediate neutrophil recruitment and kidney injury in shiga toxin-induced hemolytic uremic syndrome.
    Kidney Int. 2021;100:349-363.
    PubMed     Abstract available


  24. BOUWMEESTER RN, van de Kar NCAJ, Wetzels JFM
    Enough is enough: targeted eculizumab withdrawal in atypical hemolytic uremic syndrome.
    Kidney Int. 2021;100:265-268.
    PubMed    


    July 2021
  25. SCIESIELSKI LK, Felten M, Michalick L, Kirschner KM, et al
    The circadian clock regulates rhythmic erythropoietin expression in the murine kidney.
    Kidney Int. 2021 Jul 29. pii: S0085-2538(21)00729.
    PubMed     Abstract available


  26. IKEDA Y
    Novel roles of HIF-PHIs in chronic kidney disease: the link between iron metabolism, kidney function, and FGF23.
    Kidney Int. 2021;100:14-16.
    PubMed     Abstract available


  27. ARICETA G, Dixon BP, Kim SH, Kapur G, et al
    The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment.
    Kidney Int. 2021;100:225-237.
    PubMed     Abstract available


    June 2021
  28. KOYUN M, Kaya Aksoy G, Comak E, Ozaltin F, et al
    Outcome of diacylglycerol kinase epsilon-mediated hemolytic uremic syndrome in an infant.
    Kidney Int. 2021;99:1500-1501.
    PubMed    


    April 2021
  29. BABITT JL, Eisenga MF, Haase VH, Kshirsagar AV, et al
    Controversies in Optimal Anemia Management: Conclusions from a Kidney Disease Improving Global Outcomes (KDIGO) Conference.
    Kidney Int. 2021 Apr 8. pii: S0085-2538(21)00355.
    PubMed     Abstract available


    March 2021
  30. HANUDEL MR, Wong S, Jung G, Qiao B, et al
    Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone.
    Kidney Int. 2021 Mar 31. pii: S0085-2538(21)00354.
    PubMed     Abstract available


  31. FUCHS MAA, Broeker KAE, Schrankl J, Burzlaff N, et al
    Inhibition of transforming growth factor beta1 signaling in resident interstitial cells attenuates profibrotic gene expression and preserves erythropoietin production during experimental kidney fibrosis in mice.
    Kidney Int. 2021 Mar 8. pii: S0085-2538(21)00278.
    PubMed     Abstract available


    January 2021
  32. VILLE S, Le Bot S, Chapelet-Debout A, Blancho G, et al
    Atypical HUS relapse triggered by COVID-19.
    Kidney Int. 2021;99:267-268.
    PubMed    


    November 2020
  33. NORIS M, Remuzzi G
    Atypical hemolytic uremic syndrome associated with a factor B genetic variant and fluid-phase complement activation: an exception to the rule?
    Kidney Int. 2020;98:1084-1087.
    PubMed     Abstract available


  34. HASSANEIN M, Liaqat A, Paratore DA, Vachharajani TJ, et al
    The Case | Arrhythmias in a patient with sickle cell disease on hemodialysis.
    Kidney Int. 2020;98:1357-1358.
    PubMed    


    May 2019
  35. CAVERO T, Arjona E, Soto K, Caravaca-Fontan F, et al
    Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.
    Kidney Int. 2019 May 31. pii: S0085-2538(19)30582.
    PubMed     Abstract available


  36. CHO ME, Hansen JL, Peters CB, Cheung AK, et al
    An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease.
    Kidney Int. 2019 May 15. pii: S0085-2538(19)30506.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.